Abstract
Following the spread of the COVID-19 pandemic and pending the establishment of vaccination campaigns, several non pharmaceutical interventions such as partial and full lockdown, quarantine and measures of physical distancing have been imposed in order to reduce the spread of the disease and to lift the pressure on healthcare system. Mathematical models are important tools for estimating the impact of these interventions, for monitoring the current evolution of the epidemic at a national level and for estimating the potential long-term consequences of relaxation of measures. In this paper, we model the evolution of the COVID-19 epidemic in Belgium with a deterministic age-structured extended compartmental model. Our model takes special consideration for nursing homes which are modelled as separate entities from the general population in order to capture the specific delay and dynamics within these entities. The model integrates social contact data and is fitted on hospitalisations data (admission and discharge), on the daily number of COVID-19 deaths (with a distinction between general population and nursing home related deaths) and results from serological studies, with a sensitivity analysis based on a Bayesian approach. We present the situation as in November 2020 with the estimation of some characteristics of the COVID-19 deduced from the model. We also present several mid-term and long-term projections based on scenarios of reinforcement or relaxation of social contacts for different general sectors, with a lot of uncertainties remaining.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Namur Institute for Complex Systems (naXys) and the Department of Mathematics of the University of Namur, Belgium. The funding source played no role in study design, in the collection, analysis and interpretation of data, in the writing of the repor; and in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Minor revision.
Data Availability
All used data are available on the website of the Belgian Scientific Institute for Public Health, Sciensano. The code source is publicly available.